Protagonist Therapeutics Ownership | Who Owns Protagonist Therapeutics?
Protagonist Therapeutics Ownership Summary
Protagonist Therapeutics is owned by 99.41% institutional investors, 1.18% insiders. Farallon capital management is the largest institutional shareholder, holding 9.53% of PTGX shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.43% of its assets in Protagonist Therapeutics shares.
PTGX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Protagonist Therapeutics | 99.41% | 1.18% | -0.59% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Farallon capital management | 5.84M | 9.53% | $202.38M |
Blackrock | 5.76M | 9.39% | $199.52M |
Rtw investments, lp | 5.29M | 8.62% | $183.17M |
Bvf inc/il | 3.32M | 5.41% | $115.01M |
Vanguard group | 3.24M | 5.29% | $112.39M |
Johnson & johnson | 2.45M | 4.00% | $84.86M |
State street | 2.08M | 3.40% | $72.15M |
Jefferies financial group | 2.04M | 3.33% | $70.71M |
Adage capital partners gp | 2.00M | 3.26% | $69.35M |
Pacer advisors | 1.88M | 3.04% | $72.43M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Johnson & johnson | 2.45M | 21.18% | $84.86M |
Adar1 capital management | 1.60M | 10.49% | $55.58M |
Checkpoint capital | 355.00K | 7.42% | $12.30M |
Bvf inc/il | 3.32M | 3.22% | $115.01M |
Rtw investments, lp | 5.29M | 2.84% | $183.17M |
Kynam capital management, lp | 800.00K | 2.14% | $27.72M |
683 capital management | 604.45K | 1.58% | $20.94M |
Birchview capital, lp | 48.00K | 1.54% | $1.66M |
Eversept partners, lp | 505.84K | 1.20% | $17.53M |
Mangrove partners | 439.31K | 1.17% | $15.22M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 958.28K | 0.02% | 915.42K |
Jefferies financial group | 2.04M | 0.75% | 860.00K |
Adar1 capital management | 1.60M | 10.49% | 818.28K |
Qube research | 453.15K | 0.02% | 391.00K |
Price t rowe associates inc /md/ | 1.21M | 0.01% | 390.25K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Morgan stanley | 345.29K | 0.00% | -1.53M |
State street | 2.08M | 0.00% | -1.19M |
Fairmount funds management | - | - | -931.89K |
Bvf inc/il | 3.32M | 3.22% | -436.70K |
Marshall wace, llp | 572.18K | 0.03% | -404.72K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Eagle asset management | 357.63K | 0.07% | 357.63K | $12.59M |
Segall bryant & hamill | 118.56K | 0.07% | 118.56K | $4.11M |
Balyasny asset management | 57.50K | 0.00% | 57.50K | $1.99M |
Assenagon asset management | 52.24K | 0.00% | 52.24K | $2.02M |
Mirae asset global etfs | 32.12K | 0.00% | 32.12K | $1.11M |
Sold Out
Holder | Change |
---|---|
Mendota financial group | -6.00 |
Nelson, van denburg & campbell wealth management group | -11.00 |
Financial gravity asset management | -18.00 |
Innealta capital | -42.00 |
Truvestments capital | -131.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 246 | 27.46% | 61,406,077 | 4.02% | 99 | 1.07% | 154 | 69.23% | 65 | -7.14% |
Jun 30, 2024 | 193 | 2.66% | 59,030,802 | -1.50% | 96 | 0.99% | 91 | -17.27% | 70 | 27.27% |
Mar 31, 2024 | 188 | 18.24% | 59,929,938 | 4.29% | 98 | 1.09% | 110 | 54.93% | 55 | -9.84% |
Dec 31, 2023 | 159 | 8.90% | 57,464,862 | 1.33% | 95 | 1.04% | 71 | -12.35% | 61 | 52.50% |
Sep 30, 2023 | 146 | -19.78% | 56,712,373 | -0.03% | 95 | 0.96% | 81 | -22.12% | 40 | -16.67% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Core S&P Small-Cap ETF | 3.83M | 6.43% | 1.84K |
Pacer US Small Cap Cash Cows 100 ETF | 1.87M | 3.13% | -6.07K |
Vanguard Total Stock Mkt Idx Inv | 1.86M | 3.12% | 2.18K |
iShares Russell 2000 ETF | 1.57M | 2.63% | -6.03K |
SPDR® S&P Biotech ETF | 1.09M | 1.82% | -12.71K |
T. Rowe Price Health Sciences | 1.04M | 1.74% | -2.74K |
Vanguard Institutional Extnd Mkt Idx Tr | 894.66K | 1.50% | 17.91K |
UBS: US Equity Small Cap Growth | 744.87K | 1.26% | - |
Avantis US Small Cap Value ETF | 616.01K | 1.03% | - |
Fidelity Small Cap Index | 598.03K | 1.00% | 2.57K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Jan 16, 2025 | MOLINA ARTURO MD | Chief Medical Officer | Sell | - |
Jan 16, 2025 | MOLINA ARTURO MD | Chief Medical Officer | Sell | - |
Jan 16, 2025 | Ali Asif | Chief Financial Officer | Sell | - |
Jan 16, 2025 | Ali Asif | Chief Financial Officer | Sell | - |
Nov 27, 2024 | MOLINA ARTURO MD | Chief Medical Officer | Sell | $717.28K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 8 |
2024 Q3 | - | 4 |
2024 Q2 | - | 4 |
2024 Q1 | - | 7 |
2023 Q4 | - | 2 |
PTGX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools